Helping people save money on healthcare
Case 1 - Expensive insulin and GLP-1 analog
Patient was a long-time diabetic who was using an expensive long-acting insulin
and a drug from the GLP-1 analog class
. He recently moved back to the U.S., and he did not have health insurance. His annual adjusted gross income was less than $51,040 which meant he qualified for the Lilly Cares program. After submitting an online application, within a month he was receiving Basaglar (long-acting insulin) and Trulicity (GLP-1 analog) for free. Lilly ships the drugs directly to his home so he doesn't even have to go to the pharmacy.
Case 2 - Asthmatic who was uncontrolled on albuterol
Patient was an asthmatic who was using albuterol as needed but her symptoms were uncontrolled. She had used Flovent in the past and it helped, but it was expensive. I refilled the patient's albuterol and switched her to Airduo
which has the same drug as Flovent plus a long-acting beta agonist. Airduo is the cheapest asthma controller inhaler available right now with a cost of around $50/inhaler. I instructed the patient to use Airduo as needed because recent studies (see asthma studies
for more) have shown that using these types of inhalers as needed is just as effective as using them daily. This will also make the inhaler last longer and save more money.
Case 3 - Diabetic with insurance who still had to pay a lot for Lantus
Patient was a diabetic with a high-deductible health insurance plan. Even with insurance, her Lantus still costs hundreds of dollars a month and she was having trouble affording it. I switched her to Novolin N which costs $25/vial. Dosing Novolin N is a little trickier than Lantus, but after some slight adjustments, her blood sugars are under control and she is saving money.
Case 4 - Patient with atrial fibrillation who lost insurance
Patient had a history of atrial fibrillation, and he was taking warfarin. He lost his insurance and needed to continue his anticoagulation. Warfarin is cheap, but it requires periodic lab work. The patient lived with his wife, and together their yearly income was less than $51,720. This meant he qualified for the Bristol-Myers Squibb patient assistance program. We got him enrolled, and he now gets Eliquis® for free. Eliquis® doesn't require periodic lab monitoring, and in trials, it had a lower risk of stroke and bleeding than warfarin. (see Eliquis vs warfarin for A fib